XORTX Therapeutics Inc. Pro-forma Interim Balance Sheet

XORTX Therapeutics Inc. has filed a pro-forma interim balance sheet as of September 30, 2025, and October 16, 2025. The balance sheet highlights the company's financial position, including current and non-current assets, liabilities, and shareholders' equity. Key figures include total current assets of $1,357,479 as of September 30, 2025, and $6,061,078 as of October 16, 2025. The company's total liabilities were $837,408 as of September 30, 2025, and $987,408 as of October 16, 2025. Shareholders' equity stood at $1,973,670 as of September 30, 2025, and increased to $5,073,670 as of October 16, 2025. The filing provides a snapshot of the company's financial health and its ability to meet its obligations.